Georgia Receives Grant for Glanders Vaccine Development
Researchers at the University of Georgia (UGA) have received a three-year $1.1 million grant from the U.S. Department of Defense to develop a vaccine to protect against glanders and melioidosis, diseases caused by pathogens that pose potential